Listed
Stock Code: 475830
| Company Name | 오름테라퓨틱 주식회사 |
| English Name | Orum Therapeutics, Inc. |
| Business Reg. No. | 8878100503 |
| CEO | 이승주 |
| Address | 대전광역시 유성구 문지로 281-25 |
| Industry | 의학 및 약학 연구개발업 |
| Industry Code | 211 |
| Main Products | 용역매출 |
| Established | 2016-08-17 |
| Phone | 042-716-3030 |
| Website | Contact |
| Regular Employees | 23persons |
| Corp. Reg. No. | 1601110433518 |
Venture Certified
| 벤처투자유형 | 2016-09-13 ~ 2018-09-12 | 20160300440 | 2016-09-13 |
| 벤처투자유형 | 2018-09-13 ~ 2020-09-12 | 20180300669 | 2016-09-13 |
| 벤처투자유형 | 2020-09-13 ~ 2022-09-12 | 20200301107 | 2016-09-13 |
| 벤처투자유형 | 2022-09-13 ~ 2025-09-12 | 20220928010014 | 2016-09-13 |
| 벤처투자유형 | 2025-12-09 ~ 2028-12-08 | 20251209010051 | 2016-09-13 |
Revenue CAGR +1559.4%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 209B | 1,354B | 0.8B |
| Operating Profit | -96B | 979B | -469B |
| Net Profit | -66B | 702B | -663B |
| Total Assets | 1,576B | 1,645B | 225B |
| Total Liabilities | 435B | 402B | 180B |
| Total Equity | 1,141B | 1,243B | 45B |
Operating Loss: Op. profit -96B
Revenue down 85% YoY
▼ 69.1%
▼ 137.4%
▲ 99.9%
▼ 82.4%
▲ 99.2%
| Name | Position | Role |
|---|---|---|
| 이승주 | 대표이사 | 대표 |
| NPS Subscribers | 23persons |
| CEO | 이승주 |
| Est. Avg. Annual Salary | 6,22110K (51810K/mo) |
| Hired (12 mo) | +1persons |
| Left (12 mo) | -0persons |
| Net Change (12 mo) | +1persons |
| NPS Join Date | 2016-08-17 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 신규분해약물 접합체 | 오름테라퓨틱 주식회사 | 1020257010924 | 2023-10-06 | 공개 |
| 효과기 T세포의 활성화제 | 오름테라퓨틱 주식회사 | 1020247033423 | 2023-03-08 | 공개 |
| 항체 약물 접합체에 사용하기 위한 링커 | 오름테라퓨틱 주식회사 | 1020247011575 | 2022-09-07 | 공개 |
| 신규분해제-항-CD33 항체 접합체 | 오름테라퓨틱 주식회사|브리스톨-마이어스 스큅 컴퍼니 | 1020247000100 | 2022-06-02 | 공개 |
| 신규분해제 접합체 | 오름테라퓨틱 주식회사|브리스톨-마이어스 스큅 컴퍼니 | 1020247000099 | 2022-06-02 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "대전광역시 유성구 문지로",
"brno": "887810****",
"cappedWarning": false,
"companyName": "오름테라퓨틱주식회사",
"estimatedAvgAnnualSalary": 62214588,
"estimatedAvgMonthlySalary": 5184549,
"fetchedAt": "2026-03-05T11:41:17.846Z",
"industryCode": "730000",
"industryName": "기타 인문 및 사회과학 연구개발업",
"joinDate": "20160817",
"last12MonthsHired": 1,
"last12MonthsLeft": 0,
"last12MonthsNetChange": 1,
"leaveDate": null,
"monthlyPensionAmount": 11328240,
"monthlyTrend": [
{
"lostSubscribers": 0,
"newSubscribers": 1,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6769766",
"status": "1",
"styleCode": "1",
"subscriberCount": 23,
"turnoverMonths": 1
}{
"address": "대전 유성구",
"ceo_name": "이승주",
"certificate": [
{
"cert_number": "20160300440",
"changes": "",
"disclosure_date": "2016-09-13",
"first_cert_date": "2016-09-13",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2016-09-13 ~ 2018-09-12"
},
{
"cert_number": "20180300669",
"changes": "",
"disclosure_date": "2018-10-11",
"first_cert_date": "2016-09-13",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2018-09-13 ~ 2020-09-12"
},
{
"cert_number": "20200301107",
"changes": "",
"disclosure_date": "2020-09-24",
"first_cert_date": "2016-09-13",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2020-09-13 ~ 2022-09-12"
},
{
"cert_number": "20220928010014",
"changes": "",
"disclosure_date": "2022-09-28",
"first_cert_date": "2016-09-13",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2022-09-13 ~ 2025-09-12"
},
{
"cert_number": "20251209010051",
"changes": "",
"disclosure_date": "2025-12-09",
"first_cert_date": "2016-09-13",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2025-12-09 ~ 2028-12-08"
}
],
"company_name": "오름테라퓨틱 주식회사",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 138267184000,
"cost_of_sales": 0,
"current_assets": 11332548000,
"current_liabilities": 16703134000,
"gross_profit": 75923000,
"net_income": -66272732000,
"net_income_bs": -66272732000,
"non_current_assets": 11188680000,
"non_current_liabilities": 1320886000,
"non_operating_expenses": 20940222000,
"non_operating_income": 1524467000,
"operating_profit": -46856977000,
"revenue": 75923000,
"sga_expenses": 46932900000,
"total_assets": 22521228000,
"total_equity": 4497208000,
"total_liabilities": 18024020000
},
"2023": {
"capital_stock": 185839480000,
"cost_of_sales": 0,
"current_assets": 124752037000,
"current_liabilities": 16730557000,
"gross_profit": 135417607000,
"net_income": 70165350000,
"net_income_bs": 70057401000,
"non_current_assets": 39726624000,
"non_current_liabilities": 23445932000,
"non_operating_expenses": 29717553000,
"non_operating_income": 1955164000,
"operating_profit": 97927739000,
"revenue": 135417607000,
"sga_expenses": 37489868000,
"total_assets": 164478661000,
"total_equity": 124302172000,
"total_liabilities": 40176489000
},
"2024": {
"capital_stock": 1842912000,
"cost_of_sales": 0,
"current_assets": 120113889000,
"current_liabilities": 43288901000,
"gross_profit": 20905621000,
"net_income": -6551466000,
"net_income_bs": -6563841000,
"non_current_assets": 37517365000,
"non_current_liabilities": 207754000,
"non_operating_expenses": 8206113000,
"non_operating_income": 11210463000,
"operating_profit": -9555816000,
"revenue": 20905621000,
"sga_expenses": 30461437000,
"total_assets": 157631254000,
"total_equity": 114134599000,
"total_liabilities": 43496655000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "1,714,520,000",
"changes": "1,714,520,000",
"date": "2023-05-26"
},
{
"amount": "10,000,000,000",
"changes": "10,000,000,000",
"date": "2021-04-09"
},
{
"amount": "11,007,996,000",
"changes": "11,007,996,000",
"date": "2019-07-09"
}
],
"main_products": "용역매출",
"phone": "042-716-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Public Data | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-26 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |